April 27, 2026

Ajinomoto Group Ventures invests in optogenetic gene therapy company Restore Vision

Other news

January 7, 2026

Ajinomoto Group Ventures year in review

Read more

December 4, 2025

Ajinomoto Group Ventures invests in the Series A of optical integration company Mixx Tech

Read more

October 23, 2025

Ajinomoto Group Ventures presents cell therapy x AI panel in Boston on Nov 12, 2025

Read more